TD Waterhouse Canada’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14K | Hold |
3,203
| – | – | ﹤0.01% | 1381 |
|
2025
Q1 | $11.3K | Hold |
3,203
| – | – | ﹤0.01% | 1376 |
|
2024
Q4 | $32.2K | Buy |
+3,203
| New | +$32.2K | ﹤0.01% | 1181 |
|
2024
Q1 | – | Sell |
-137
| Closed | -$1.7K | – | 1865 |
|
2023
Q4 | $1.7K | Hold |
137
| – | – | ﹤0.01% | 1514 |
|
2023
Q3 | $2.49K | Buy |
137
+66
| +93% | +$1.2K | ﹤0.01% | 1473 |
|
2023
Q2 | $1.9K | Hold |
71
| – | – | ﹤0.01% | 1543 |
|
2023
Q1 | $4.22K | Hold |
71
| – | – | ﹤0.01% | 1405 |
|
2022
Q4 | $3.45K | Hold |
71
| – | – | ﹤0.01% | 1418 |
|
2022
Q3 | $6.07K | Hold |
71
| – | – | ﹤0.01% | 1321 |
|
2022
Q2 | $5K | Hold |
71
| – | – | ﹤0.01% | 1392 |
|
2022
Q1 | $8.54K | Hold |
71
| – | – | ﹤0.01% | 1363 |
|
2021
Q4 | $7.8K | Buy |
+71
| New | +$7.8K | ﹤0.01% | 1383 |
|